Performance of a second‐generation methylated SEPT9 test in detecting colorectal neoplasm
The DOI matches its Crossref record.
Abstract
Background and Aim: Screening and early detection reduces mortality due to colorectal cancer (CRC). Methylated Septin 9 (SEPT9) is a new blood‐based biomarker for CRC. We evaluated the performance of the second‐generation SEPT9 assay for the detection of colorectal neoplasm, and compared it with fecal immunochemical test (FIT). Methods: A total of 135 patients with CRC, 169 with adenomatous polyps, 81 with hyperplastic polyps, and 91 healthy controls were included. The clinical status of all subjects was verified by colonoscopy. In all patients, peripheral blood samples were taken for SEPT9 testing using Epi proColon 2.0 test. For 177 patients, both SEPT9 and FIT were performed. Results: The sensitivity and specificity of SEPT9 for CRC were 74.8% (95% confidence interval [CI]: 67.0–81.6%) and 87.4% (vs non‐CRC, 95% CI: 83.5–90.6%), respectively. SEPT9 was positive in 66.7% of stage I, 82.6% of stage II, 84.1% of stage III, and 100% of stage IV CRC s. The sensitivity of SEPT9 for advanced adenomas was 27.4% (95% CI: 18.7–37.6%). The sensitivity and specificity of FIT for CRC was 58.0% (95% CI: 46.1–69.2%) and 82.4% (95% CI: 74.4–88.7%), respectively. SEPT9 showed better performance in CRC detection than FIT, but similar among advanced adenomas. Conclusions: With improved performance characteristics in detecting CRC, the second‐generation SEPT9 assay could play an important role in CRC screening and early detection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001122 · Cited by 853
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications
Cao, Q., Tian, Y., Deng, Z., Yang, F., & Chen, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063358 · Cited by 60
Metadata
- Authors
- Jin, P., Kang, Q., Wang, X., Yang, L., Yu, Y., Li, N., He, Y., Han, X., Hang, J., Zhang, J., Song, L., Han, Y., & Sheng, J.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2015-04-10
- Volume
- 30
- Issue
- 5
- Pages
- 830-833
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2140915515
- Cited by
- 146
- References
- 0
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Performance of a second‐generation methylated SEPT9 test in detecting colorectal neoplasm. https://app.cochat.ai/papers/10.1111/jgh.12855
- The paper
- Jin, P., Kang, Q., Wang, X., Yang, L., Yu, Y., Li, N., He, Y., Han, X., Hang, J., Zhang, J., Song, L., Han, Y., & Sheng, J. (2015). Performance of a second‐generation methylated SEPT9 test in detecting colorectal neoplasm. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.12855
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.